Postmarketing Surveillance Study for Quadrivalent Influenza Vaccine (VaxigripTetra®) in Subjects Aged 6 to 35 Months

NCT05832333 · clinicaltrials.gov ↗
COMPLETED
Status
682
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Sanofi